Background and purpose: Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods: Forty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results: On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions: It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease involving both upper and lower motor neurons, leading to progressive limb paralysis and bulbar involvement. Mean survival time from disease onset is usually 3-5 years [1] , with death occurring mostly secondary to respiratory failure. The disease is characterized by wide heterogeneity in the clinical presentation and in the progression rate [2] , with some patients surviving 10 years or more [3, 4] . For these reasons, there is an emerging need for specific biomarkers that could help in the characterization of clinical phenotypes and in prognosis evaluation.
Previous studies have proposed different prognostic factors as determinant for survival estimation in ALS, including demographic and clinical parameters, the most reliable being age, site of onset, bulbar Correspondence: P.-F. Pradat, APHP, Hôpital Piti e-Salpêtriere, D epartement des Maladies du Syst eme Nerveux, Centre r ef erent SLA, 47 Boulevard de l' Hôpital, 75013 Paris, France (tel.: +33 0142162471; fax: +33 0142162735; e-mail: pierre-francois.pradat @aphp.fr). 1 First co-authors. involvement, diagnostic delay, functional status and disability progression rate [5] . However, clinical and demographic variables do not allow a reliable approximation in prognosis prediction when considered alone [6] . A combination of these variables with biochemical, neuroimaging and neurophysiological methods may increase the power of prediction. Within them, magnetic resonance imaging (MRI) techniques are used not only in the diagnostic process but also as potential biomarkers of disease progression [7] . In comparison to brain imaging, spinal cord MRI has the advantage of investigating at the same time upper and lower motor neurons. However, spinal cord imaging has technical limitations due to the small diameter of the spinal cord, physiological motions (respiratory and cardiac movements) and susceptibility artefacts. In recent years, technical improvements, such as higher spatial resolution and respiratory/cardiac gating, have allowed advanced MRI sequences to be applied to spinal cord studies [8] . Thanks to the improvement of spinal cord segmentation methods, it is now possible to accurately measure spinal cord atrophy in many disease conditions, including motor neuron diseases [9] . By combining spinal cord MRI and electrophysiology (transcranial magnetic stimulation) in ALS patients, it has been shown that spinal cord atrophy is a marker of lower motor neuron degeneration, whilst diffusion tensor imaging (DTI) and the magnetization transfer ratio (MTR) that measure white matter integrity are related to degeneration of corticospinal tracts (CST) [10] . Using multi-parametric MRI approaches combining DTI, MTR and atrophy measurements, several studies have demonstrated abnormalities in the cervical cord of ALS patients compared to healthy controls [10] [11] [12] [13] . Some of these abnormalities have been correlated with scores of clinical disability and with disease progression rate [14] ; in particular, it has been demonstrated that atrophy rate is related to disease progression [15] and that spinal cord cross-sectional area (CSA) and MTR are more reliable markers of longitudinal neurodegeneration than DTI metrics [8] .
To further improve knowledge about the use of MRI parameters as early determinants of patients' prognosis and to determine if they could be predictive when used in combination with clinical parameters, the possible correlation between MRI and survival was studied in a cohort of 49 ALS patients.
Methods

Subjects
The local ethics committee of our institution approved all experimental procedures and written informed consent was obtained from each participant.
Forty-nine patients with probable or definite ALS were enrolled in the study and underwent a cervical cord MRI together with clinical and functional examination. Demographic data and clinical history of the patients were collected as well. The following variables were extracted for all patients from the center's database: gender; age at first symptoms; disease duration between symptoms' onset and diagnosis; site of onset; body mass index at first examination.
Revised ALS Functional Rating Scale (ALSFRS-R) [16] data were obtained. ALSFRS-R subscores pertaining to bulbar, upper limbs, truncal, lower limbs and respiratory function were calculated.
The progression rate at baseline of the ALSFRS-R score was defined by:
where D is the progression rate at baseline, ALSFRS Max = 48 is the ALSFRS-R score for a healthy subject, ALSFRS MRI is the ALSFRS-R score at MRI, and s is the delay between first symptoms and MRI (in months). The patients were also scored on manual muscle testing (MMT) using the Medical Research Council score [17] . Seven muscles in each limb were assessed and a total score for upper and lower limbs was calculated.
Patients were followed for mortality both through contacts with their families or treating physicians and through the national mortality register until 31 May 2016. Mortality was taken as the time of death or of tracheostomy.
Magnetic resonance imaging acquisition and data processing
Acquisitions were performed using a 3 T MRI system (TIM Trio, Siemens Healthcare, Erlangen, Germany). Anatomical imaging was performed at the cervical and upper thoracic spinal cord levels. DTI and magnetization transfer imaging were performed at the cervical levels from C2 to C7 using the following protocol.
Anatomical data were acquired using a sagittal T2-weighted three-dimensional turbo spin echo (TSE) image with slab selective excitation. Imaging parameters were isotropic voxel size 0.9 9 0.9 9 0.9 mm 3 ; FOV = 280 9 280 mm 2 ; 52 sagittal slices; TR = 1500 ms; echo time TE = 120 ms; acceleration factor 3; acquisition time 6 min.
The CSA was measured by an operator experienced on the segmentation technique on the T2ÀTSE images in the middle of vertebral levels. Data were segmented using a double threshold-based method, an improved version of the well-established threshold-based method, with minimal manual intervention [18, 19] . This technique has been previously validated by our group in healthy subjects and in patients affected by various neurological diseases including motor neuron diseases [18] . It has been demonstrated to be highly accurate at the cervical cord region [19] .
Diffusion tensor imaging [20] data were acquired using a single shot echo-planar imaging sequence with monopolar diffusion weighting scheme to achieve low TE. The acquisition was cardiac-gated. Imaging parameters were voxel size 1 9 1 9 5 mm 3 ; FOV = 128 9 128 mm 2 ; TR = 700 ms; TE = 96 ms; acceleration factor 2; b value = 1000 s/mm 2 ; 64 diffusion encoding directions; four averages; acquisition time 15 min.
Data were corrected for motion slice-by-slice using FSL FLIRT [20] with three degrees of freedom (T x , T y , R z ). Diffusion metrics were estimated voxel-wise using FSL DTIFIT: FA, radial diffusivity (k ┴ ), axial diffusivity (k ⁄⁄ ) and mean diffusivity (MD).
Three-dimensional gradient echo images with slabselective excitation were acquired with and without magnetization transfer (MT) saturation pulse (Gaussian envelope, duration 9984 ls, frequency offset 1200 Hz). Imaging parameters were voxel size 0.9 9 0.9 9 2 mm 3 ; FOV = 230 9 230 mm 2 ; axial orientation with 52 slices (covering the same C2-T2 region as the DTI scans), flip angle 23°, TR = 28 ms; TE = 3.2 ms; acquisition time, 5 min per volume. MTR was computed voxel-wise using the equation MTR = 100 9 (S 0 À S MT )/S 0 , where S 0 and S MT represent the signal without and with the magnetization transfer pulse, respectively.
The lateral portion of the cord, which includes mostly the CST, was delineated manually and using geometry-based information by an experienced operator on segmentation. To minimize bias, these regions of interest (ROIs) were defined on the mean diffusion weighted images (for DTI analysis) and on the 3D gradient echo T1-weighted image (for MT analysis). Figure 1 describes an example of multi-parametric cervical spinal cord MRI in an ALS patient. Both T1-and T2-weighted images representative of those used for atrophy measurements and estimation of DTI and MTR data are shown.
Statistical analysis
Statistical analysis was performed using JMP 12. Demographic and clinical data are described as mean AE standard deviation. The false discovery rate correction was used for multiple correlations.
For survival analyses, participants were followed from entry to death, date of censoring alive or 31 May 2016, whichever occurred first. Survival was plotted by baseline characteristics using the Kaplan-Meier method. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Univariate analyses were first conducted in which each covariate was entered separately. Then multivariate analyses including MRI parameters and significant variables associated with mortality were performed. A backwards stepwise selection procedure was used with a P value of 0.10 for staying in the model. The significance level was set at P < 0.05.
Results
Demographic and clinical data of the patients are summarized in Table 1 whilst descriptive statistics relative to MRI parameters are summarized in Table 2 .
Survival analysis
Of the 49 patients, 30 had died by the end of the study (61%). Median survival time from MRI to death was 40.19 AE 22.44 months. Median survival time was 42.53 months. Age at MRI was 55.52 AE 9.80 years.
No significant difference in survival was found when dividing the patients according to the mean age at MRI.
General survival of the observed population was described using the Kaplan-Meyer method as shown in Fig. 2 . FA, fractional anisotropy; AD, axial diffusivity; RD, radial diffusivity; MD, mean diffusivity; MTR, magnetization transfer ratio; CSA, cross-sectional area.
Univariate Cox proportional hazards models A univariate analysis was performed using a Cox proportional hazards model to find which clinical-demographic variables influenced survival significantly. Total MMT (P = 0.005) and MMT for upper limbs (P = 0.025), progression rate at baseline of the ALSFRS-R score (P = 0.04) and disease duration between symptom onset and diagnosis (P = 0.007) influenced survival significantly.
Multivariate Cox proportional hazards models
A multivariate Cox regression model was fitted using clinical variables which were found to be significant in the univariate analysis together with the MRI variables. A significance level of 0.10 was used as the cutoff to stay in the model. The total MMT on MRI and the rate of ALSFRS-R decline were predictors of survival in the final model. Within MRI parameters, FA (P = 0.008), MTR (P = 0.01) and CSA at the C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels (respectively P = 0.03, P = 0.03, P = 0.01, P = 0.02) were significant.
The HR calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with spinal cord atrophy at these levels (respectively HR = 0.66, P < 0.001, 95% CI 0.43-1.00; and HR = 0.68, P < 0.001, 95% CI 0.46-0.90). They were more predictive than clinical variables which had HR very close to 1, indicating a poor prediction power: HR = 0.94 for disease duration from onset to MRI (95% CI 0.86-1.1), 1.1 for ALSFRS-R progression rate (95% CI 1.03-1.23) and 0.94 for total MMT (95% CI 0.90-0.97).
Discussion
Our study suggests that multi-parametric cervical spinal cord MRI is useful for survival prediction in ALS patients. Indeed, MRI parameters are described as predictive of survival in our cohort, with HR related to CSA indicating a relation between focal cervical cord atrophy and shorter disease duration.
From a pathological point of view, ALS is characterized by simultaneous degeneration of both upper and lower motor neurons and the complex clinical picture of the disease is determined by a combination of the two [21, 22] . A description of changes over time both in brain and spinal cord has been proposed and, in recent years, neuroimaging has come out as a valid non-invasive tool in the analysis of pathological disease evolution. Degeneration in the spinal cord manifests as involvement of both white matter of CST and grey matter related to the loss of motor neurons [23] . These changes alter the diffusivity properties of the cord, usually manifesting as a progressive increase in MD and decrease in FA [8] . In a recent study, it has been shown that abnormalities in the cervical spinal cord detected combining DTI, MTR and atrophy measurements correlated with functional impairment [14] .
Starting from these previous observations, the aim was to demonstrate that MRI parameters can be supportive also in prognosis evaluation. The CSA reduction in the cervical cord was shown to be associated with shorter survival. Respiratory dysfunction, which is the main cause of death in ALS patients, is closely related to the degeneration of motor neurons innervating the diaphragm that are located in the cervical cord. At the same time, it is demonstrated that FA and MTR values also influence survival, in accordance with the role of white matter involvement in the complex neurological picture and progression rate in ALS.
Here it is proposed that MRI parameters referring to white matter and grey matter degeneration should be considered together since they mirror the complexity of pathological changes happening in vivo. Such complexity and the fact that degeneration involves many systems at the same time account for the wide variability in clinical phenotypes and for the difficulty in building accurate models predicting survival. In fact, even though research in ALS has been progressing in many fields, a reliable biomarker and predictor of prognosis is still missing [24] . Nevertheless, it would be of primary importance in better management of patients and in patients' stratification during clinical trials [25] . Spinal cord MRI could be an effective biomarker and would be widely disposable and non-invasive.
One limitation of our study is that patients with great disability or important bulbar or respiratory involvement are often not able to lie down for a long time within the MRI scanner. Due to this classical selection bias, common to all neuroimaging studies in ALS patients, our population may not be completely representative of a whole ALS population which limits the generalization of the results. Another limitation is that brain MRI, which has been shown recently to predict survival using deep learning [26] , was not included. Combination with brain MRI as well as more complex models such as deep learning could improve prediction and should be explored in future work.
In conclusion, our data support the hypothesis that spinal cord MRI could be useful when performed in patients at the beginning of the disease to better classify them and to recognize slowly progressing from fast progressing patients. However, the validation of a biomarker is a complex and multistep process [27] which requires confirmation of the results in large and independent populations. For this reason, our data will need further validation in independent and larger cohorts of patients.
